Drug · DIN 02559773
ANDEMBRY
SINGLE-USE PREFILLED PEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 24, 2025; first marketed October 24, 2025.
- Drug Identification Number (DIN)
- 02559773
- Company (DIN owner)
- Csl Behring Canada IncOttawa, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Garadacimab B06AC07
- Class
- Human
- Record last updated
- October 8, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GARADACIMAB | 200 MG | 1.2 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 6, 2025: NOC 35821New Drug Submission (NDS)
Other DINs named ANDEMBRY
- DIN 02559765 · Approved